Polymeric additives to enhance the functional properties of calcium phosphate cements
Publication date
2012-03-20ISSN
2041-7314
Abstract
The vast majority of materials used in bone tissue engineering and regenerative medicine are based on calcium phosphates due to their similarity with the mineral phase of natural bone. Among them, calcium phosphate cements, which are composed of a powder and a liquid that are mixed to obtain a moldable paste, are widely used. These calcium phosphate cement pastes can be injected using minimally invasive surgery and adapt to the shape of the defect, resulting in an entangled network of calcium phosphate crystals. Adding an organic phase to the calcium phosphate cement formulation is a very powerful strategy to enhance some of the properties of these materials. Adding some water-soluble biocompatible polymers in the calcium phosphate cement liquid or powder phase improves physicochemical and mechanical properties, such as injectability, cohesion, and toughness. Moreover, adding specific polymers can enhance the biological response and the resorption rate of the material. The goal of this study is to overview the most relevant advances in this field, focusing on the different types of polymers that have been used to enhance specific calcium phosphate cement properties.
Document Type
Article
Document version
Accepted version
Language
English
Subject (CDU)
611 - Anatomy. Human and comparative anatomy
Keywords
Pages
20
Publisher
Journal of Tissue Enineering
Recommended citation
Perez, R. A., Kim, H. W., & Ginebra, M. P. (2012). «Polymeric additives to enhance the functional properties of calcium phosphate cements». Journal of tissue engineering, vol. 3, núm. 1, art. 2041731412439555. Disponible en: <https://journals.sagepub.com/doi/10.1177/2041731412439555>. Fecha de acceso: 21 oct. 2019. DOI: 10.1177/2041731412439555
Grant agreement number
info:eu-repo/grantAgreement/EC/FP7/241879
info:eu-repo/grantAgreement/ES/MICINN/MAT 2009-13547
Note
The research in Dr Kim’s group is supported by Priority Research Centers Program (grant no. 2009-0093829) and World Class University (WCU) program (grant no. R31-10069) through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology. The research in Dr Ginebra’s group is funded by the Spanish Ministry of Science and Innovation (MAT 2009-13547 project) and the Generalitat de Catalunya through the prize “ICREA Academia” for excellence in research, and the European Commission through (FP7/2007-2013) under grant agreement no. 241879, REBORNE project.
This item appears in the following Collection(s)
- Ciències de la Salut [980]
Rights
https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/

